Compass Therapeutics Inc (NASDAQ: CMPX) is 70.34% higher on its value in year-to-date trading and has touched a low of $0.76 and a high of $2.68 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CMPX stock was last observed hovering at around $2.00 in the last trading session, with the day’s gains setting it 0.47%.
Currently trading at $2.47, the stock is 53.75% and 53.68% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.5 million and changing 23.50% at the moment leaves the stock 67.99% off its SMA200. CMPX registered 36.46% gain for a year compared to 6-month gain of 135.24%. The firm has a 50-day simple moving average (SMA 50) of $1.5906 and a 200-day simple moving average (SMA200) of $1.46789.
The stock witnessed a 63.58% loss in the last 1 month and extending the period to 3 months gives it a 25.70%, and is 72.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 29.92% over the week and 13.77% over the month.
Compass Therapeutics Inc (CMPX) has around 32 employees, a market worth around $339.85M and $0.85M in sales. Profit margin for the company is -5618.71%. Distance from 52-week low is 222.88% and -7.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.00%).
The EPS is expected to shrink by -6.06% this year
110.0 institutions hold shares in Compass Therapeutics Inc (CMPX), with institutional investors hold 79.06% of the company’s shares. The shares outstanding are 137.59M, and float is at 84.48M with Short Float at 2.62%. Institutions hold 69.17% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 22.36 million shares valued at $22.36 million. The investor’s holdings represent 16.3701 of the CMPX Shares outstanding. As of 2024-06-30, the second largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with 11.13 million shares valued at $11.13 million to account for 8.1474 of the shares outstanding. The other top investors are BLACKSTONE INC. which holds 7.69 million shares representing 5.6304 and valued at over $7.69 million, while BLACKROCK INC. holds 4.8413 of the shares totaling 6.61 million with a market value of $6.61 million.
